InvestorsHub Logo

Tuff-Stuff

01/24/15 8:01 AM

#47460 RE: Tuff-Stuff #47459

NPSP<>NPS Pharmaceuticals announces FDA approval of Natpara
NPS Pharmaceuticals announced that the U.S. FDA has approved Natpara as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism. Hypoparathyroidism is a rare endocrine disorder characterized by insufficient levels of parathyroid hormone, or PTH. Natpara, a bioengineered replica of human PTH, is expected to be available in the second quarter of 2015.

Tuff-Stuff

01/27/15 6:02 AM

#47646 RE: Tuff-Stuff #47459

<-click back, lipstick thread: RANsquawk: TPG Capital said to be in talks with $AVP which B. Riley suggests could be a US $14/sh. ·Jan. 27 at 3:29 AM


oH that would be more then $3 buck chux x 550...Lets Rock and ROLL!!